IXICO plc (AIM:IXI)

Market Cap	9.50M
Revenue (ttm)	6.44M
Net Income (ttm)	-1.55M
Shares Out	92.67M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,820
Average Volume	96,319
Open	10.50
Previous Close	10.25
Day's Range	10.00 - 10.50
52-Week Range	6.60 - 15.00
Beta	0.66
RSI	40.05
Earnings Date	Aug 19, 2025

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 81
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.